Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants

BackgroundAntibiotics, as the most commonly prescribed class of drugs in neonatal intensive care units, have an important impact on the developing neonatal gut microbiota. Therefore, comprehending the effects of commonly used antibiotic therapy on the gut microbiota and butyrate-producers in early i...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Qiu, Sha Wu, Ruiwen Huang, Zhenyu Liao, Xiongfeng Pan, Kunyan Zhao, Yunlong Peng, Shiting Xiang, Yunhui Cao, Ye Ma, Zhenghui Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2024.1508217/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555958933749760
author Jun Qiu
Jun Qiu
Sha Wu
Sha Wu
Ruiwen Huang
Zhenyu Liao
Xiongfeng Pan
Kunyan Zhao
Kunyan Zhao
Yunlong Peng
Yunlong Peng
Shiting Xiang
Yunhui Cao
Yunhui Cao
Ye Ma
Zhenghui Xiao
Zhenghui Xiao
author_facet Jun Qiu
Jun Qiu
Sha Wu
Sha Wu
Ruiwen Huang
Zhenyu Liao
Xiongfeng Pan
Kunyan Zhao
Kunyan Zhao
Yunlong Peng
Yunlong Peng
Shiting Xiang
Yunhui Cao
Yunhui Cao
Ye Ma
Zhenghui Xiao
Zhenghui Xiao
author_sort Jun Qiu
collection DOAJ
description BackgroundAntibiotics, as the most commonly prescribed class of drugs in neonatal intensive care units, have an important impact on the developing neonatal gut microbiota. Therefore, comprehending the effects of commonly used antibiotic therapy on the gut microbiota and butyrate-producers in early infants could provide information for therapeutic decision-making in the NICU.ObjectivesTo explore the effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants.MethodsA total of 72 infants were included in the study. We performed 16S rRNA sequencing on stool swab samples collected from neonatal intensive care unit patients who received amoxicillin-clavulanic acid (AC, n = 10), moxalactam (ML, n = 28) and non-antibiotics (NA, n = 34). We then compared the taxonomic composition between treatment regimens, focusing on differences in butyrate-producers.ResultsOur study showed that there were significant differences in Shannon index (p = 0.033) and Beta diversity (p = 0.014) among the three groups. At the family level, compared with the other two groups, the relative abundance of Clostridiaceae (p < 0.001) and Veillonellaceae (p = 0.004) were significantly higher, while the relative abundance of Enterococcidae (p < 0.001) was significantly lower in the NA group. The relative abundance of Enterobacteriaceae (p = 0.022) in the AC group was greater than that in the other two groups. Additionally, butyrate-producers (p < 0.001), especially Clostridiaceae (p < 0.001), were noticeably more abundant in the NA group. The relative abundance of Clostridiaceae and butyrate-producers were the lowest in the ML group (p < 0.001).ConclusionWe found that antibiotic therapy had an adverse impact on the initial development of gut microbiota and leaded to a reduction in the abundance of butyrate-producers, particularly Clostridiaceae. Furthermore, moxalactam had a more pronounced effect on the gut microbiota compared to amoxicillin-clavulanic acid.
format Article
id doaj-art-27371e663fd943279876a8f943ce298b
institution Kabale University
issn 1664-302X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-27371e663fd943279876a8f943ce298b2025-01-07T15:03:07ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-01-011510.3389/fmicb.2024.15082171508217Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infantsJun Qiu0Jun Qiu1Sha Wu2Sha Wu3Ruiwen Huang4Zhenyu Liao5Xiongfeng Pan6Kunyan Zhao7Kunyan Zhao8Yunlong Peng9Yunlong Peng10Shiting Xiang11Yunhui Cao12Yunhui Cao13Ye Ma14Zhenghui Xiao15Zhenghui Xiao16The School of Pediatrics, Hengyang Medical School, University of South China, Hunan Children’s Hospital, Hengyang, Hunan, ChinaPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, ChinaThe School of Pediatrics, Hengyang Medical School, University of South China, Hunan Children’s Hospital, Hengyang, Hunan, ChinaPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, ChinaDepartment of Neonatology, Hunan Children's Hospital, Changsha, Hunan, ChinaDepartment of Neonatology, Hunan Children's Hospital, Changsha, Hunan, ChinaPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, ChinaPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, ChinaThe School of Public Health, University of South China, Hengyang, ChinaPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, ChinaDepartment of Epidemiology and Health Statistics, Medical College of Soochow University, Suzhou, ChinaPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, ChinaThe School of Pediatrics, Hengyang Medical School, University of South China, Hunan Children’s Hospital, Hengyang, Hunan, ChinaPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, ChinaDepartment of Neonatology, Hunan Children's Hospital, Changsha, Hunan, ChinaThe School of Pediatrics, Hengyang Medical School, University of South China, Hunan Children’s Hospital, Hengyang, Hunan, ChinaDepartment of Emergency Center, Hunan Children’s Hospital, Changsha, ChinaBackgroundAntibiotics, as the most commonly prescribed class of drugs in neonatal intensive care units, have an important impact on the developing neonatal gut microbiota. Therefore, comprehending the effects of commonly used antibiotic therapy on the gut microbiota and butyrate-producers in early infants could provide information for therapeutic decision-making in the NICU.ObjectivesTo explore the effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants.MethodsA total of 72 infants were included in the study. We performed 16S rRNA sequencing on stool swab samples collected from neonatal intensive care unit patients who received amoxicillin-clavulanic acid (AC, n = 10), moxalactam (ML, n = 28) and non-antibiotics (NA, n = 34). We then compared the taxonomic composition between treatment regimens, focusing on differences in butyrate-producers.ResultsOur study showed that there were significant differences in Shannon index (p = 0.033) and Beta diversity (p = 0.014) among the three groups. At the family level, compared with the other two groups, the relative abundance of Clostridiaceae (p < 0.001) and Veillonellaceae (p = 0.004) were significantly higher, while the relative abundance of Enterococcidae (p < 0.001) was significantly lower in the NA group. The relative abundance of Enterobacteriaceae (p = 0.022) in the AC group was greater than that in the other two groups. Additionally, butyrate-producers (p < 0.001), especially Clostridiaceae (p < 0.001), were noticeably more abundant in the NA group. The relative abundance of Clostridiaceae and butyrate-producers were the lowest in the ML group (p < 0.001).ConclusionWe found that antibiotic therapy had an adverse impact on the initial development of gut microbiota and leaded to a reduction in the abundance of butyrate-producers, particularly Clostridiaceae. Furthermore, moxalactam had a more pronounced effect on the gut microbiota compared to amoxicillin-clavulanic acid.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1508217/fullgut microbiotaantibioticsamoxicillin-clavulanic acidmoxalactambutyrate-producers
spellingShingle Jun Qiu
Jun Qiu
Sha Wu
Sha Wu
Ruiwen Huang
Zhenyu Liao
Xiongfeng Pan
Kunyan Zhao
Kunyan Zhao
Yunlong Peng
Yunlong Peng
Shiting Xiang
Yunhui Cao
Yunhui Cao
Ye Ma
Zhenghui Xiao
Zhenghui Xiao
Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
Frontiers in Microbiology
gut microbiota
antibiotics
amoxicillin-clavulanic acid
moxalactam
butyrate-producers
title Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
title_full Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
title_fullStr Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
title_full_unstemmed Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
title_short Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
title_sort effects of antibiotic therapy on the early development of gut microbiota and butyrate producers in early infants
topic gut microbiota
antibiotics
amoxicillin-clavulanic acid
moxalactam
butyrate-producers
url https://www.frontiersin.org/articles/10.3389/fmicb.2024.1508217/full
work_keys_str_mv AT junqiu effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT junqiu effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT shawu effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT shawu effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT ruiwenhuang effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT zhenyuliao effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT xiongfengpan effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT kunyanzhao effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT kunyanzhao effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT yunlongpeng effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT yunlongpeng effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT shitingxiang effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT yunhuicao effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT yunhuicao effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT yema effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT zhenghuixiao effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants
AT zhenghuixiao effectsofantibiotictherapyontheearlydevelopmentofgutmicrobiotaandbutyrateproducersinearlyinfants